2017-002851-27: GENETIC SEQUENCING FOR THE TREATMENT OF ADVANCED SOFT-TISSUE SARCOMAS SEQUENCAGE GENETIQUE POUR LE TRAITEMENT DES SARCOMES DES TISSUS MOUS |
|
|
| Not yet recruiting | 3 | 960 | Europe | CAPMATINIB, OLAPARIB, DURVALUMAB, GLASDEGIB, TAS-120, INC280, AZD2281, MEDI4736, PF-04449913, TAS-120, Capsule, hard, Film-coated tablet, Concentrate for solution for infusion, Tablet, TASIGNA, ZYKADIA, TYVERB, MEKINIST, TAFINLAR, LYNPARZA, IBRANCE | INSERM, Institut National du Cancer (INCa) | Adult patients with locally advanced/unresectable and/or metastatic soft-tissue sarcoma, Adult patients with advanced soft-tissue sarcoma, Diseases [C] - Cancer [C04] | | | | |
NCT02386826: INC280 Combined With Bevacizumab in Patients With Glioblastoma Multiforme |
|
|
| Completed | 1 | 65 | US | INC280, INCB28060, bevacizumab, Avastin | SCRI Development Innovations, LLC, Novartis | Glioblastoma Multiforme, Gliosarcoma, Colorectal Cancer, Renal Cell Carcinoma | 07/21 | 08/23 | | |
